The rising prevalence of cardiovascular disease such as heart failure is expected to boost the Cardiac Resynchronization Therapy Devices Market

Cardiac Resynchronization Therapy Devices Market

DelveInsight’s Cardiac Resynchronization Therapy (CRT) Devices market report provides an in-depth understanding of Cardiac Resynchronization Therapy devices as well as historical and forecasted Cardiac Resynchronization Therapy Devices market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and the UK), and Japan. The report also examines Cardiac Resynchronization Therapy Devices market drivers, Cardiac Resynchronization Therapy Devices market barriers, and unmet needs.

Some of the Important Findings from the Cardiac Resynchronization Therapy Devices Market Report

• The key Medtech companies active in the Cardiac Resynchronization Therapy Devices domain include Boston Scientific Corporation, Medtronic, Medico S.p. A, Microport Scientific Corporation, Biotronik, EBR Systems Inc, Abbott, among others.

• DYNAGEN™ X4 is a Boston Scientific Corporation trademarked product that addresses the requirement for defibrillators in Cardiac Resynchronization Therapy.

• The REPLYTM CRT-P by Microport Scientific Corporation is the smallest CRT pacemaker in the world. It has functions like sleep apnea monitoring. It has dual sensors, which meet the requirement for precise Rate Response in CRT.

• Other approved devices in the Cardiac Resynchronization Therapy market include QUADRA ASSURA MPTM CRT-D (Abbott), COBALT XT (Medtronic), Enticos 8 HF-T QP / HF-T (Biotronik), and others.

• The Cardiac Resynchronization Therapy Devices market is segmented by Product and End User.

Request for the sample to know more about the CRT @ Cardiac Resynchronization Therapy vs Pacemaker

The Cardiac Resynchronization Therapy Devices market report includes an overview of Cardiac Resynchronization Therapy Devices, their applications, and a PEST Analysis. The report also includes information on the Cardiac Resynchronization Therapy Devices market share and the present and expected market size for Cardiac Resynchronization Therapy Devices from 2018 to 2026, segmented by seven key markets.

Cardiac Resynchronization Therapy: Overview

Cardiac Resynchronization Therapy (CRT), also known as biventricular pacing, is a type of therapy used to treat patients who have advanced heart failure or ventricular dyssynchrony. The pacing of the left ventricle (LV) and almost or completely simultaneous pacing of the right ventricle are involved in the therapy to improve ventricular synchrony and thereby improving LV systolic function. Two major devices are used to do CRT: CRT-D (cardiac resynchronization therapy defibrillator) and CRT-P (cardiac resynchronization therapy pacemaker).

Cardiac Resynchronization Therapy Devices Market 

The Cardiac Resynchronization Therapy Device market is segmented into product type and end-user. The Cardiac Resynchronization Therapy Devices market is highly consolidated, with a wide range of products available. The presence of major players, such as Abbott, Biotronik, Boston Scientific Corporation, Medtronic, among others, dominates the Cardiac Resynchronization Therapy Devices market.

Among the EU-5 countries, France accounted for the highest market size for Cardiac Resynchronization Therapy Devices while Spain had the lowest Cardiac Resynchronization Therapy Devices market share.

Find out which player or device is going to get the max market share @ Cardiac Resynchronization Therapy Devices

Cardiac Resynchronization Therapy Devices Key Companies 

• Boston Scientific Corporation

• Medtronic

• Medico S.p. A

• Microport Scientific Corporation

• Biotronik

• EBR Systems Inc

• Abbott

Cardiac Resynchronization Therapy Devices Market Drivers 

• A surge in the prevalence of cardiovascular diseases

• The rising geriatric population is susceptible to heart failure.

• Sedentary lifestyle

Cardiac Resynchronization Therapy Devices Market Barriers

• Product recalls

• Stringent regulatory process

Cardiac Resynchronization Therapy Devices Unmet Needs 

• Few products are available which may limit options for patients

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2018-26

Cardiac Resynchronization Therapy Devices Key Companies: Boston Scientific Corporation, Medtronic, Medico S.p. A, Microport Scientific Corporation, Biotronik, EBR Systems, Inc, Abbott, among others. 

Tools Used: PEST Analysis

KOL’s Views

Table of Contents

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts

Related Reports

Cardiac Ablation Devices

Get a comprehensive analysis of Urinary Incontinence Devices Market pipeline devices and key companies including Advanced Cardiac Therapeutics, Alcon Laboratories Inc, AngioDynamics, Inc., AtriCure, Inc., Biosense Webster Inc, Boston Scientific Corporation, CONMED Corporation, Medtronic, Olympus Corporation, St Jude Medical, Inc., among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/